Evolocumab
ATC C10AX13 · 10 markets · 24 records
US 5 records · 1 strengths
- 140 mginjectionREPATHA
AU 4 records · 3 strengths
- 140 mginjectionREPATHA evolocumab (rch) 140 mg/mL injection solution syringeREPATHA evolocumab (rch) 140 mg/mL injection solution syringe within a pen injector
- 140 mg/1 mLinjectionREPATHA
Records without a stated strength · 1 REPATHA
ES 3 records · 2 strengths
- 140 mginjectionREPATHA PRECARGADA
- 140 mg/1 mLinjectionREPATHA PRECARGADA
GB 2 records · 1 strengths
- 140 mg/1 mLinjectionRepatha 140mg/1ml solution for injection pre-filled syringesRepatha SureClick 140mg/1ml solution for injection pre-filled pens
SG 2 records · 1 strengths
- 140 mg/mLinjectionREPATHA SOLUTION FOR INJECTION IN PRE-FILLED AUTOINJECTOR 140MG/MLREPATHA SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 140MG/ML
TW 2 records · 1 strengths
Records without a stated strength · 1 "Amgen" Repatha Solution for Injection、"安進"瑞百安注射液、Repatha Solution for Injection、瑞百安注射液
HK 2 records · 1 strengths
Records without a stated strength · 1 REPATHA SOLUTION FOR INJECTION IN PRE-FILLED AUTOINJECTOR 140MG/ML、REPATHA SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 140MG/ML
CA 1 records · 1 strengths
- 140 mgliquidREPATHA
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 REPATHA
| Strength / form / release | US | GB | CA | AU | SG | ES | TW | HK | EU |
|---|---|---|---|---|---|---|---|---|---|
| 140 mg injection | REPATHA | REPATHA evolocumab (rch) 140 mg/mL injection solution syringe REPATHA evolocumab (rch) 140 mg/mL injection solution syringe within a pen injector | REPATHA PRECARGADA | ||||||
| 140 mg/1 mL injection | Repatha 140mg/1ml solution for injection pre-filled syringes Repatha SureClick 140mg/1ml solution for injection pre-filled pens | REPATHA | REPATHA PRECARGADA | ||||||
| 140 mg/mL injection | REPATHA SOLUTION FOR INJECTION IN PRE-FILLED AUTOINJECTOR 140MG/ML REPATHA SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 140MG/ML | ||||||||
| 140 mg liquid | REPATHA | ||||||||
injection | "Amgen" Repatha Solution for "安進"瑞百安 Repatha Solution for+1瑞百安 | ||||||||
unknown | REPATHA | REPATHA SOLUTION FOR INJECTION IN PRE-FILLED AUTOINJECTOR 140MG/ML REPATHA SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 140MG/ML | REPATHA |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
2 more strength/form rows are recorded only in CA · SG and are not shown in this table. Hay 2 filas de concentración/forma registradas solo en CA · SG que no se muestran en esta tabla. 另有 2 个规格/剂型仅在 CA · SG 有记录(未在本表显示)。 另有 2 個規格/劑型僅在 CA · SG 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.